Literature DB >> 33574148

Understanding the complexity of socioeconomic disparities in smoking prevalence in Sweden: a cross-sectional study applying intersectionality theory.

Sten Axelsson Fisk1, Martin Lindström2,3, Raquel Perez-Vicente4, Juan Merlo4,3.   

Abstract

OBJECTIVES: Socioeconomic disparities in smoking prevalence remain a challenge to public health. The objective of this study was to present a simple methodology that displays intersectional patterns of smoking and quantify heterogeneities within groups to avoid inappropriate and potentially stigmatising conclusions exclusively based on group averages.
SETTING: This is a cross-sectional observational study based on data from the National Health Surveys for Sweden (2004-2016 and 2018) including 136 301 individuals. We excluded people under 30 years of age, or missing information on education, household composition or smoking habits. The final sample consisted on 110 044 individuals or 80.7% of the original sample. OUTCOME: Applying intersectional analysis of individual heterogeneity and discriminatory accuracy (AIHDA), we investigated the risk of self-reported smoking across 72 intersectional strata defined by age, gender, educational achievement, migration status and household composition.
RESULTS: The distribution of smoking habit risk in the population was very heterogeneous. For instance, immigrant men aged 30-44 with low educational achievement that lived alone had a prevalence of smoking of 54% (95% CI 44% to 64%), around nine times higher than native women aged 65-84 with high educational achievement and living with other(s) that had a prevalence of 6% (95% CI 5% to 7%). The discriminatory accuracy of the information was moderate.
CONCLUSION: A more detailed, intersectional mapping of the socioeconomic and demographic disparities of smoking can assist in public health management aiming to eliminate this unhealthy habit from the community. Intersectionality theory together with AIHDA provides information that can guide resource allocation according to the concept proportionate universalism. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  epidemiology; health policy; public health; social medicine; statistics & research methods; substance misuse

Year:  2021        PMID: 33574148      PMCID: PMC7880088          DOI: 10.1136/bmjopen-2020-042323

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  43 in total

Review 1.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors:  Margaret Sullivan Pepe; Holly Janes; Gary Longton; Wendy Leisenring; Polly Newcomb
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

Review 2.  Socioeconomic status and smoking: a review.

Authors:  Rosemary Hiscock; Linda Bauld; Amanda Amos; Jennifer A Fidler; Marcus Munafò
Journal:  Ann N Y Acad Sci       Date:  2011-11-17       Impact factor: 5.691

3.  Can intersectionality theory enrich population health research?

Authors:  Mark A Green; Clare R Evans; S V Subramanian
Journal:  Soc Sci Med       Date:  2017-02-22       Impact factor: 4.634

4.  An intersectional approach to multilevel analysis of individual heterogeneity (MAIH) and discriminatory accuracy.

Authors:  Maria Wemrell; Shai Mulinari; Juan Merlo
Journal:  Soc Sci Med       Date:  2017-03-01       Impact factor: 4.634

5.  An Intersectional Analysis of Women's Experiences of Smoking-Related Stigma.

Authors:  Zoi Triandafilidis; Jane M Ussher; Janette Perz; Kate Huppatz
Journal:  Qual Health Res       Date:  2016-10-13

6.  Gender equality and smoking: a theory-driven approach to smoking gender differences in Spain.

Authors:  Usama Bilal; Paula Beltrán; Esteve Fernández; Ana Navas-Acien; Francisco Bolumar; Manuel Franco
Journal:  Tob Control       Date:  2015-02-20       Impact factor: 7.552

7.  Gender and class as dimensions of smoking behaviour in Britain: insights from a survey of mothers.

Authors:  H Graham
Journal:  Soc Sci Med       Date:  1994-03       Impact factor: 4.634

8.  Chronic Obstructive Pulmonary Disease in Sweden: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy.

Authors:  Sten Axelsson Fisk; Shai Mulinari; Maria Wemrell; George Leckie; Raquel Perez Vicente; Juan Merlo
Journal:  SSM Popul Health       Date:  2018-03-20

9.  Differences in socioeconomic and gender inequalities in tobacco smoking in Denmark and Sweden; a cross sectional comparison of the equity effect of different public health policies.

Authors:  Frida Eek; Per-Olof Ostergren; Finn Diderichsen; Niels K Rasmussen; Ingelise Andersen; Kontie Moussa; Mathias Grahn
Journal:  BMC Public Health       Date:  2010-01-09       Impact factor: 3.295

10.  Educational differences in smoking among adolescents in Germany: what is the role of parental and adolescent education levels and intergenerational educational mobility?

Authors:  Benjamin Kuntz; Thomas Lampert
Journal:  Int J Environ Res Public Health       Date:  2013-07-19       Impact factor: 3.390

View more
  3 in total

1.  Social capital, the miniaturization of community, traditionalism and mortality: A population-based prospective cohort study in southern Sweden.

Authors:  Martin Lindström; Mirnabi Pirouzifard; Maria Rosvall
Journal:  SSM Popul Health       Date:  2021-11-06

2.  The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden.

Authors:  Malin Spetz; Lisa Lundberg; Chioma Nwaru; Huiqi Li; Ailiana Santosa; Susannah Leach; Magnus Gisslén; Niklas Hammar; Maria Rosvall; Fredrik Nyberg
Journal:  Lancet Reg Health Eur       Date:  2022-02-26

3.  An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden.

Authors:  M Spetz; L Lundberg; C Nwaru; H Li; A Santosa; N Ng; S Leach; M Gisslén; N Hammar; F Nyberg; M Rosvall
Journal:  Vaccine       Date:  2022-09-28       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.